Historical Summary of Tick and Animal Surveillance Studies for Lyme Disease in Canada, 1975–2023: A Scoping Review
Zoonoses and Public Health · 2025
DOI: 10.1111/zph.13191 ↗Kurz gefasst
Scoping Review in der Zeitschrift Zoonoses and Public Health, 2025. Verfasst von Alexander Davidson und 5 weiteren Autor:innen. Beteiligte Einrichtung: Vaccines and Antivirals Medical Affairs, Pfizer Inc., New York, New York, USA. Hauptthemen laut MEDLINE: Lyme Disease. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 151 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Valneva, Pfizer.
Abstract (Originalsprache)
Introduction
Lyme disease (LD) is caused by infection with the bacteria Borrelia burgdorferi sensu lato ( Bb ) through the bite of an infected Ixodes spp. tick. LD has emerged as a public and animal health issue in Canada, with human incidence increasing in part due to the expansion of Ixodes scapularis ticks and their vertebrate hosts. We sought to provide the first comprehensive summary of published tick and animal surveillance literature regarding LD in Canada to describe changes in LD over time.
Methods
We conducted a review to identify peer‐reviewed LD‐focused tick, mammal, and bird surveillance articles in three online databases between 1975 and 2023. Data on study characteristics, data collection years, and surveillance methods and findings were extracted. Descriptive statistics were reported.
Results
In total, 115 studies were included for review. Results showed an increase in published surveillance literature and changes in study approaches and their provincial distribution over time, coinciding with increased LD cases in Canada. Seventy‐four studies were published after 2014 when Canada's Federal Framework on Lyme Disease Act was introduced, and two‐thirds of these studies focused on tick surveillance only. Overall, 58% of studies involved surveillance in Ontario but increases in all other provinces were observed after 2009.
Conclusions
Observed changes in five decades of LD‐related tick and animal surveillance literature helps document the historical rapid spread of Ixodes and Bb across provinces. This can provide lessons for other regions that may transition from emerging to endemic status for LD in the coming years.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Vaccines and Antivirals Medical Affairs, Pfizer Inc., New York, New York, USA.
- Life Sciences, Clarivate Analytics, Chandler, Arizona, USA.
- Vaccines Medical Affairs, Pfizer Canada ULC, Kirkland, Quebec, Canada.
- Vaccines and Antivirals Medical Affairs, Pfizer Inc., Paris, France.
- Vaccines and Antivirals Medical Affairs, Pfizer Inc., Cambridge, Massachusetts, USA.
ORCID-Profile: Alexander Davidson, Patrick H Kelly, Julie Davis, James H Stark
Förderung
- Valneva
- Pfizer
Zitieren
APA
Davidson, A., Kelly, P. H., Davis, J., Major, M., Moïsi, J. C., & Stark, J. H. (2025). Historical Summary of Tick and Animal Surveillance Studies for Lyme Disease in Canada, 1975–2023: A Scoping Review. Zoonoses and Public Health. https://doi.org/10.1111/zph.13191
Vancouver
Davidson A, Kelly PH, Davis J, Major M, Moïsi JC, Stark JH. Historical Summary of Tick and Animal Surveillance Studies for Lyme Disease in Canada, 1975–2023: A Scoping Review. Zoonoses and Public Health. 2025. doi:10.1111/zph.13191
BibTeX
@article{Davidson2025,
author = {Davidson, Alexander and Kelly, Patrick H and Davis, Julie and Major, Maria and Moïsi, Jennifer C and Stark, James H},
title = {Historical Summary of Tick and Animal Surveillance Studies for Lyme Disease in Canada, 1975–2023: A Scoping Review},
journal = {Zoonoses and Public Health},
year = {2025},
doi = {10.1111/zph.13191}
}
EUVIMED